The pharmaceutical death-ride of dihydroartemisinin
<p>Abstract</p> <p>In the 2010 second edition of WHO's guidelines for the treatment of malaria, the relatively new fixed dose combination dihydroartemisinin-piperaquine is included as one of the recommended artemisinin combination therapies. However, experimental testing demon...
Main Author: | Jansen Frans |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/9/1/212 |
Similar Items
-
Resistance to Dihydroartemisinin
by: Sandrine Cojean, et al.
Published: (2006-11-01) -
Resistance to Dihydroartemisinin
by: Sandrine Cojean, et al.
Published: (2007-05-01) -
Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells.
by: Qiuyan Wang, et al.
Published: (2015-01-01) -
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
by: Tzu-En Huang, et al.
Published: (2020-11-01) -
Redetermination of dihydroartemisinin at 103 (2) K
by: Jerry P. Jasinski, et al.
Published: (2008-01-01)